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cense.Abstract A spectrophotometric method and two titrimetric methods for the determination of
nordiazepam via its iodobismuthate complex are described. These methods depend on the reaction
of nordiazepam with potassium bismuth iodide which give an orange precipitate. Determination of
nordiazepam in the precipitated complex is done iodometrically using standard potassium iodate
solution or complexometrically using standard EDTA solution and xylenol orange indicator. Alter-
natively, the complex is dissolved in ethanol and its absorbance is measured at 323 nm. The three
methods were applied for the determination of reference samples of nordiazepam in the concentra-
tion range of 1–30 mg ml1 (for the iodometric method) and of 5–30 mg ml1(for the complexomet-
ric method) and of 0.04–3.2 mg ml1 (for the spectrophotometric method). The proposed methods
were applied for the determination of nordiazepam in madar tablets and the validity of the pro-
posed methods was assessed by applying the standard addition technique.
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lsevier1. Introduction
Nordiazepam (N-desmethyldiazepam) is an example of benzo-
diazepine drugs which are used as anxiolytics, minor tranquil-
lizers and psychotropic drugs (William, 1989). The therapeutic
interest in these compounds justiﬁes research to establish ana-
lytical methods for their determination in pharmaceutical for-
mulations (Schutz, 1984).The wide use of this group of drugs
make extensive literature on the analysis of these compounds.
Several methods have been reported for the quantitative deter-
mination of nordiazepam and other benzodiazepines including
spectrophotometry (Garcia et al., 1983; Tan et al., 1999; El
Bardicy et al., 1993; Martinez and Gimenez, 1981; Randez
et al., 1991), ﬂuorimetry (Manes and Yakatan, 1975),
10 N.M. Mostafa, E.H. AlGohanicolorimetry (Stevens, 1978; EL-Shabouri and Sidhom, 1985),
polarographic (Brooks and Silva, 1975), titrimetric (Barbato
et al., 1979) and chromatographic methods (Robert et al.,
2008; Kauppila et al., 2007; Ngwa et al., 2007; Rosa and
Sue, 2007; Laloup et al., 2007; Stephane et al., 2006; Aure´lie
and Christian, 2004; Lambert et al., 1995; Azzam et al.,
1998; Reubaet et al., 1998; Kintz et al., 1996; Estadien et al.,
1989; Kudo et al., 1988; Nitzche et al., 1984; Sun, 1978; San-
chez et al., 1986; Schuetz and Schneider, 1985; Walles et al.,
2004; Archonate et al., 1998; Atta et al., 1999; Mura et al.,
1987; Sanchez et al., 1983, 1986).2. Experimental
2.1. Chemicals and reagents– Nordiazepam reference standard, obtained from ravizza,
Italy.
– Madar tablets labeled to contain 10 mg of nordiazepam
obtained from Arab drug Co. for Pharm. Cairo, Egypt
(Batch No. 109025).2.2. Solutions preparation– Stock bismuth oxynitrate solution, 0.25 M.
– Dissolve 7.30 g of bismuth oxynitrate in 25 ml of hydro-
chloric acid and dilute the solution to 100 ml with water.
– Potassium iodide solution, 40% w/v in ascorbic acid
solution.
– Dissolve 40 g of potassium iodide in 1% aqueous ascorbic
acid solution, and dilute to 100 ml with the same
solution.
– Iodobismuthic acid solution prepared by adding 20 ml of
the stock bismuth solution to 15 ml of potassium
iodide solution and then dilute the mixture with
65 ml of water while stirring (this reagent must be freshly
prepared).
– Potassium iodobismuthate solution (B.P 1988), dissolve
10 g of tartaric acid in 40 ml water, add 0.85 g bismuth oxy-
nitrate shake during 1 h, add 20 ml of 40% w/v solution of
potassium iodide and shake well. Allow to stand for 24 h,
and then ﬁlter.
– Standard potassium iodate solution 0.005 M, dissolve 1.07
g of potassium iodate, analytical reagent grade, in distilled
water and dilute the solution to 1 L.
– Standard EDTA solution 0.01 M, dissolve 3.722 g of ana-
lytical reagent grade ethylene-diamine tetra acetic acid diso-
dium salt in sufﬁcient volume of distilled water and dilute
the solution to 1 L. Standardize the prepared reagent
against standard zinc solution using ammonia buffer and
Eriochrome black T as indicator.
– Xylenol orange indicator 0.1% w/v aqueous solution.
– Hydrochloric acid 0.1 N.
– Nordiazepam solution 2 mg ml1 and 5 mg ml1 in 0.1 N
hydrochloric acid.
– Absolute alcohol, prolabo.
3. Apparatus
UV–Vis Spectrophotometer, Shimadzu 1800.4. Procedures
4.1. Spectrophotometric determination of nordiazepam via its
iodobismuthate complex
Transfer aliquot portions (0.2–1.6 ml) of N-desmethyldiaze-
pam reference sample solution (2 mg ml1) to a series of
10 ml centrifuge tubes, add 1 ml potassium iodobismuthate
solution (B.P 1988) and mix well.
Allow to stand at room temperature for 5 min then centri-
fuge the mixtures for 5 min and decant. Wash the precipitate
three times each with 5 ml 0.1 N hydrochloric acid. Centrifuge
and decant. Transfer the content of the centrifuge tube to a
10 ml measuring ﬂask using three successive portions each of
2 ml ethyl alcohol and complete to volume with the same sol-
vent. Measure the absorbance of the solutions at 323 nm
against ethyl alcohol as a blank. The absorbances at 323 nm
produced by 0.04–0.32 mg ml1 of nordiazepam are plotted
against the respective concentration.4.1.1. Determination of the composition of nordiazepam
iodobismuthate complex
The continuous variation method and the mole ratio method
were applied to determine the composition of nordiazepam
iodobismuthate complex.
4.1.1.1. Continuous variation method (Inczedy, 1976). Proce-
dure: Add 0, 0.1, 0.2, . . . and 1 ml of 102 M nordiazepam
solution in 0.1 N hydrochloric acid to 1, 0.9, 0.8, . . . and
0 ml of 102 M iodobismuthate solution, respectively, to a ser-
ies of 10 ml centrifuge tubes. Complete as under procedure A.4.1.1.2. The mole – ratio method (Inczedy, 1976). Procedure:
Introduce 1 ml 102 M potassium iodobismuthate solution
to a series of 10 ml centrifuge tubes containing different vol-
umes of 102M nordiazepam (0.2, 0.4, 0.6, . . ., 2.2 ml) com-
plete as under procedure A.4.2. Complexometric determination of nordiazepam via its
iodobismuthate
Transfer aliquot portions (1–6 ml) of nordiazepam solution
(5 mg ml1) to a series of 10 ml centrifuge tubes, to each tube
add 5 ml iodobismuthic acid solution and mix well.
Allow to stand at room temperature for 5 min and decant
the supernatant liquid, wash the precipitate three times each
with 5 ml 0.1 N HCl, followed by centrifugation for 5 min
and decant.
Quantitatively transfer the contents of each centrifuge tube
to a 250 ml separating funnel using about 2 ml nitric acid and
150 ml of water, add 20 ml chloroform to extract the liberated
iodine. Transfer the chloroformic layer into a 250 ml separat-
ing funnel and wash it thoroughly with two portions each of
20 ml distilled water. Collect the aqueous washings and aque-
ous layer into a 250 ml conical ﬂask. Adjust the acidity of the
combined aqueous solution to pH 1–3 (using pH meter), add
three drops xylenol orange indicator and titrate with 0.01 M
EDTA till full yellow color.
Each 1 ml of 0.01 M EDTA is equivalent to 5.414 mg
nordiazepam.
Figure 1 Determination of the stoichiometry of the reaction of
nordiazepam and iodobismuthate by the continuous variation
method.
Figure 2 Determination of the stoichiometry of the reaction of
nordiazepam and iodobismuthate by the mole ratio method.
Table 1 Regression equation parameters of the spectropho-
tometric method for the analysis of nordiazepam in pure
powder form.
Parameter Spectrophotometric method
Concentration range (mg ml1) 0.04–3.2
Intercept (a)a 0.007
Slop (b)a 2.01
Correlation coeﬃcient 0.998
a Regression equation: Y= bc+ a, where Y is the absorbance, a
is the intercept, b is the slop and c is the concentration.
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iodobismuthate complex
Quantitatively transfer the precipitate (prepared as detailed
under procedure B using aliquot portions 0.2–6 ml of nord-
iazepam solution) from each centrifuge tube to a 250 ml glass
stopper conical ﬂask using 20 ml water and 40 ml concentrated
hydrochloric acid. Shake well until the precipitate dissolve
completely and titrate the solution with 0.005 M potassium io-
date using chloroform as indicator. Each 1 ml of 0.005 M
KIO3 is equivalent to 1.353 mg nordiazepam.
4.4. Application of the proposed method to the determination of
nordiazepam in madar tablets
Weigh and powder twenty tablets. Transfer a quantity of pow-
der equivalent to 20 mg nordiazepam (for spectrophotometric
method) or 50 mg nordiazepam (for titrimetric method) to a
10 ml volumetric ﬂask add 4 ml 0.1 N hydrochloric acid and
shake for 5 min. Dilute to volume with distilled water and ﬁl-
ter. Nordiazepam was determined according the procedures
described before under Procedure 4.1, 4.2 and 4.3.
5. Results and discussion
Nordiazepam bismuth iodide complex was prepared by react-
ing nordiazepam with potassium bismuth iodide in acid med-
ium (0.1 N hydrochloric acid) which gives an orange
precipitated complex.
Spectrophotometric determination of nordiazepam via its
iodobismuthate complex is done by reacting the drug with
potassium iodobismuthate reagent (B.P 1988) not iodobismu-
thic acid which gives no sharp absorption peak. The absorp-
tion spectrum of nordiazepam iodobismuthate complex in
ethyl alcohol exhibits a maximum at 323 nm. The effect of time
on the stability of the formed complex solution in ethanol was
studied by monitoring periodically at one minute interval the
absorbance of a solution of the complex in ethanol at
323 nm using ethanol as a blank.
The absorbances at 323 nm produced by 0.04–0.32 mg ml1
of nordiazepam are plotted against the respective concentra-
tions. According to the results of the linearity, the correspond-
ing regression equation is computed and found to be:
Y ¼ 2:01 Cþ 0:007 r ¼ 0:998
where Y is the absorbance of the complex at 323 nm. C is the
concentration in mg.
The continuous variation method and the mole ratio meth-
od were applied to determine the composition of nordiazepam
iodobismuthate complex spectrophotometrically. The continu-
ous variation method is applied to determine the ratio of nord-
iazepam–iodobismuthate in the complex as under (Procedure
4.1.1.1) The principle of the method is that the mole – ratio
of the metal ion and ligand is varied between 0 and 1 at con-
stant total concentration C= CL + CM and the absorbance
of the solution of different composition is measured. The
absorbances are then plotted against the mole fraction XL of
the ligand. This method revealed a ratio of 2:1 under the de-
scribed condition as shown in Fig. 1.
The stoichiometry of the reaction of nordiazepam and iod-
obismuthate is also determined by the mole ratio method as
under (Procedure 4.1.1.2). The principle of the methoddepends on preparing a series of solutions in which the concen-
tration of one component (usually CM) is kept constant and
that of the other is varied.
The absorbances of the solution are measured at the suit-
able wavelength and then plotted against the ratio of the var-
iable and constant concentration (CL/CM). With the increase
Table 2 Determination of nordiazepam in pure powder, in pharmaceutical dosage form and application of standard addition
technique.
Proposed method Pure powder Pharmaceutical dosage form Standard addition technique
Recovery% Recovery% Recovery%
Spectrophotometric method 99.61 ± 2.44 98.26 ± 1.09 96.87 ± 1.59
Complexometric method 99.71 ± 0.47 99.45 ± 0.41 99.66 ± 0.51
Iodometric method 99.08 ± 1.37 99.95 ± 0.91 99.84 ± 0.37
Table 3 Statistical comparison between the results of the proposed method and the reference method.
Item Spectrophotometric method Complexometric method Iodometric method Reference method El Bardicy et al. (1993)
Mean 98.26 99.45 99.95 99.37
n 8 6 6 5
SD 1.07 0.39 0.915 0.71
Variance 1.145 0.152 0.837 0.504
Student t(0.975) test 0.261(2.201) 0.251(2.262) 1.173(2.262)
F ratio 2.27(5.7) 3.32(3.8) 1.66(5.2)
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and then become constant.
The abscissa of the point of intersection of the two tangents
give the number of ligands in the complex (the ligand concen-
tration that was varied). This method revealed a ratio of 2:1
nordiazepam–iodobismuthate, as shown in Fig. 2.
Adopting the proposed procedure to determine different
amount of authentic samples of nordiazepam, the concentra-
tion were calculated from the computed regression equation
(Table 1), the results are shown in Table 2.
According to the mole ratio, the equivalence factors were
calculated and subsequently used for the calculation of nord-
iazepam concentration in the two titrimetric methods. The
complexometric method involves titration of the dissolved
complex (bismuth content) with standard EDTA using xylenol
orange indicator. The acidity of the solution is adjusted at pH
1:3. Each 1 ml of 0.01 M EDTA is equivalent to 5.414 mg
nordiazepam.
Using the proposed procedure to determine different
amounts of authentic sample of nordiazepam (5–30 mg ml1),
the concentrations were calculated according to the equivalence
factor giving a mean percentage of 99.71 ± 0.47 as shown in
Table 2.
Iodometric determination of nordiazepam in the precipi-
tated complex involves titrating the dissolved complex (iodine
content) with standard potassium iodate solution and chloro-
form indicator, as under Procedure 4.3.
According to the mole ratio of nordiazepam and iodobi-
smuthate, the equivalence factor was calculated for the iodo-
metric method and used for the calculation of nordiazepam
concentration. Each 1 ml of 0.005 M KIO3 solution is equiva-
lent to 1.353 mg nordiazepam.
Using the proposed method to determine different amounts
of authentic sample of nordiazepam (1–30 mg ml1) the con-
centrations were calculated according to the equivalence factor
giving a mean percentage recovery of 99.08 ± 1.37, as shown
in Table 2.
The proposed procedure was applied to the determination
of nordiazepam in madar tablets. The results are given in
Table 2. To evaluate the accuracy of the procedure when ap-plied to the pharmaceutical preparation control experiments
were performed by adding known concentration of the authen-
tic nordiazepam to a previously analyzed aliquots of the tab-
lets powder and the accuracy of the recovery of the added
nordiazepam is computed, as shown in Table 2.
It is evident that the percentage recoveries of the added
nordiazepam have almost the same accuracy as those obtained
with the authentic nordiazepam. Statistical comparison be-
tween the results of the suggested methods and the reference
method (El Bardicy et al., 1993) was carried out using (t) test
and variance ratio (F), as shown in Table 3. It is clear that the
calculated (t) and (F) values are less than the corresponding
theoretical values indicating that no signiﬁcant differences be-
tween the methods with respect to both precision and
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